Please upload a copy of your presentation slides. This will allow attendees to follow along with your presentation
Are you attending the CRS Annual Meeting because of your interest in Drug Delivery and Controlled Release Systems?
Many of these delivery systems are administered orally. You may be a clinician in search of better clinical outcomes, a chemist with pioneering new molecules, an industrial formulator with challenging APIs, a product owner in search of life-cycle management strategies for your drug product or an engineer looking for advanced manufacturing technologies i.e. widely different motivations for attending this conference and workshop. Attending this workshop is a must, as you'll have access to a group of seasoned presenters in oral drug delivery who have ‘been there and done that’ with a wealth of experience of both successes and setbacks. This presents a unique opportunity to delve into the intricacies of formulating, developing, and manufacturing oral dosage forms, leveraging cutting-edge science and technology. The agenda contains fundamentals, current hot topics as well as cutting edge forthcoming technologies backed with science and applications. There will be interactive discussions and real-life case studies to showcase challenges and potential solutions. Join us at this workshop to exchange insights, identify valuable resources, and navigate the complex landscape of oral drug delivery with confidence.
09:00 – 9:10 am Welcome and Introductions
Ali Rajabi-Siahboomi, Daniel Treffer & Daniel Bar-Shalom
09:10 – 09:45 am Understanding Oral Route for Drug Delivery
Clive Wilson, UK
09:45 – 10:20 am Designing Oral Drug Delivery Formulation
Ali Rajabi-Siahboomi, Colorcon, USA
10:20 – 10:55 am Critical Development Considerations of Oral Drug Delivery Dosage Forms
Anisul Quadir, Shin-Etsu, USA
10:55 – 11:10 am Morning Break
11:10 – 11:45 am Functional Ready-to-Fill Capsules for Accelerated Pharma Developments
Felix Hofmann, Evonik, Germany
11:45 – 12:20 pm Application of HPMCAS as Stabilizer / Precipitation Inhibitor for ASDs
Anette Mullertz, Bioneer, Denmark
12:20 – 1:20 pm Lunch
1:20 – 1:55 pm Oral Delivery of Macromolecules
David Brayden, University College Dublin, Ireland
1:55 – 2:30 pm MED 3D Printing Technology, Product Development and Manufacturing
Xiaoling Li, Triastek, China
2:30 – 3:05 pm Enabling APIs at Milligram Scale
Daniel Treffer, MeltPrep, USA
3:05 – 3:20 pm Afternoon Break
3:20 – 3:55 pm Oral Delivery of Bioactive Ingredients Through Novel Microencapsulation
Tom Kamperman, IamFluidics, Netherlands
3:55 – 4:20 pm Advanced Simulations and PAT Tools for Pellet Coating
Johannes Khinast, RCPE, Austria
4:20 – 5:00 pm General Q&A and Closing Remarks
Ali Rajabi-Siahboomi, PhD (he/him/his)
Chief Innovation Officer
Colorcon
harleysville, Pennsylvania, United States
Daniel Treffer, PhD (¯\_(ツ)_/¯)
CEO
MeltPrep
Graz, Steiermark, Austria
Clive G. Wilson, PhD
Research Professor
Strathclyde Institute Of Pharmacy and BioMedical Sciences
Glasgow, United Kingdom
Anisul Quadir, PhD (he/him/his)
Technical Director
Shin-Etsu Chemical Company Ltd
Totowa, New Jersey, United States
David J. Brayden, PhD (he/him/his)
Professor of Advanced Drug Delivery
University College Dublin
Dublin, Ireland
Xiaoling Li, PhD (he/him/his)
Professor
University of the Pacific
Stockton, California, United States
Tom Kamperman, PhD (he/him/his)
CTO & co-founder
IamFluidics BV
Enschede, Overijssel, Netherlands